Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 14, 2023, titled "Sun Pharma and Pharmazz Inc. enter into licensing agreement for introducing Tyvalzi (Sovateltide) in India".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 14, 2023, titled "Sun Pharma and Pharmazz Inc. enter into licensing agreement for introducing Tyvalzi (Sovateltide) in India".